Cite
O'Hara J, Finnegan A, Dhillon H, et al. Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study. JHEP Rep. 2020;2(5):100142doi: 10.1016/j.jhepr.2020.100142.
O'Hara, J., Finnegan, A., Dhillon, H., Ruiz-Casas, L., Pedra, G., Franks, B., Morgan, G., Hebditch, V., Jönsson, B., Mabhala, M., Reic, T., Van Thiel, I., Ratziu, V., Romero-Gomez, M., Bugianesi, E., Schattenberg, J. M., & Anstee, Q. M. (2020). Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study. JHEP reports : innovation in hepatology, 2(5), 100142. https://doi.org/10.1016/j.jhepr.2020.100142
O'Hara, Jamie, et al. "Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study." JHEP reports : innovation in hepatology vol. 2,5 (2020): 100142. doi: https://doi.org/10.1016/j.jhepr.2020.100142
O'Hara J, Finnegan A, Dhillon H, Ruiz-Casas L, Pedra G, Franks B, Morgan G, Hebditch V, Jönsson B, Mabhala M, Reic T, Van Thiel I, Ratziu V, Romero-Gomez M, Bugianesi E, Schattenberg JM, Anstee QM. Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study. JHEP Rep. 2020 Jul 15;2(5):100142. doi: 10.1016/j.jhepr.2020.100142. eCollection 2020 Oct. PMID: 32775976; PMCID: PMC7397699.
Copy
Download .nbib